| Ident. | Authors (with country if any) | Title |
|---|
| 000141 |
Angelo Antonini [Italie] ; Pablo Martinez-Martin [Espagne] ; Ray K. Chaudhuri [Royaume-Uni] ; Marcelo Merello [Argentine] ; Robert Hauser [États-Unis] ; Regina Katzenschlager [Autriche] ; Per Odin [Allemagne] ; Mark Stacy [États-Unis] ; Fabrizio Stocchi [Italie] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Anette Schrag [Royaume-Uni] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] | Wearing‐off scales in Parkinson's disease: Critique and recommendations |
| 000144 |
Anne Pavy-Le Traon [France] ; Gerard Amarenco [France] ; Susanne Duerr [Autriche] ; Horacio Kaufmann [États-Unis] ; Heinz Lahrmann [Autriche] ; Stephanie R. Shaftman [États-Unis] ; François Tison [France] ; Gregor K. Wenning [Autriche] ; Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Anette Schrag [Royaume-Uni] ; Glenn T. Stebbins [États-Unis] ; Olivier Rascol [France] | The Movement Disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension |
| 000145 |
Klaus Seppi [Autriche, Portugal] ; Daniel Weintraub [États-Unis] ; Miguel Coelho [Portugal] ; Santiago Perez-Lloret [France] ; Susan H. Fox [Canada] ; Regina Katzenschlager [Autriche] ; Eva-Maria Hametner [Autriche] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz [États-Unis] ; Cristina Sampaio [Portugal] | The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease |
| 000146 |
Susan H. Fox [Canada] ; Regina Katzenschlager [Autriche] ; Shen-Yang Lim [Malaisie] ; Bernard Ravina [États-Unis] ; Klaus Seppi [Autriche] ; Miguel Coelho [Portugal] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz [États-Unis] ; Cristina Sampaio [Portugal] | The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease |
| 000148 |
Albert F. G. Leentjens [Pays-Bas] ; Kathy Dujardin [France] ; Laura Marsh [États-Unis] ; Pablo Martinez-Martin [Espagne] ; Irene H. Richard [États-Unis] ; Sergio E. Starkstein [Australie] | Symptomatology and markers of anxiety disorders in Parkinson's disease: A cross‐sectional study |
| 000149 |
Hélène Mollion [France] ; Peter Ford Dominey [France] ; Emmanuel Broussolle [France] ; Jocelyne Ventre-Dominey [France] | Subthalamic nucleus stimulation selectively improves motor and visual memory performance in Parkinson's disease |
| 000157 |
Cristina Sampaio [Portugal] ; Juliana Bronzova [Pays-Bas] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Serge V. Van De Witte [Pays-Bas] ; And Ad Theeuwes [Pays-Bas] | Pardoprunox in early Parkinson's disease: Results from 2 large, randomized double‐blind trials |
| 000159 |
Veit Mylius [Allemagne, France] ; Juliane Brebbermann [Allemagne] ; Helena Dohmann [Allemagne] ; Isabel Engau [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Jens C. Möller [Allemagne, Suisse, France] | Pain sensitivity and clinical progression in Parkinson's disease |
| 000160 |
Benjamin Dehay [France] ; Erwan Bezard [France] | New animal models of Parkinson's disease |
| 000164 |
Caroline Moreau [France] ; Odile Pennel-Ployart [France] ; Serge Pinto [France] ; Audrey Plachez [France] ; Agnes Annic [France] ; François Viallet [France] ; Alain Destée [France] ; Luc Defebvre [France] | Modulation of dysarthropneumophonia by low‐frequency STN DBS in advanced Parkinson's disease |
| 000165 |
Olivier Rascol [France] ; Andres Lozano [Canada] ; Matthew Stern [États-Unis] ; Werner Poewe [Autriche] | Milestones in Parkinson's disease therapeutics |
| 000170 |
Ingrid De Chazeron [France] ; Pierre-Michel Llorca [France] ; Isabelle Chéreau-Boudet [France] ; Olivier Blanc [France] ; Jean Perriot [France] ; Lemlih Ouchchane [France] ; Miguel Ulla [France] ; Bérengère Debilly [France] ; Philippe Derost [France] ; Franck Durif [France] | Hypersexuality and pathological gambling in Parkinson's disease: A cross‐sectional case–control study |
| 000171 |
Pablo Martinez-Martin [Espagne] ; Martine Jeukens-Visser [Pays-Bas] ; Kelly E. Lyons [États-Unis] ; C. Rodriguez-Blazquez [Espagne] ; Caroline Selai [Royaume-Uni] ; Andrew Siderowf [États-Unis] ; Mickie Welsh [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] ; Anette Schrag [Royaume-Uni] | Health‐related quality‐of‐life scales in Parkinson's disease: Critique and recommendations |
| 000174 |
Serge Pinto [France] ; Laura Mancini [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] ; John S. Thornton [Royaume-Uni] ; Elina Tripoliti [Royaume-Uni] ; Tarek A. Yousry [Royaume-Uni] ; Patricia Limousin [Royaume-Uni] | Functional magnetic resonance imaging exploration of combined hand and speech movements in Parkinson's disease |
| 000179 |
Estelle Dellapina [France] ; Angélique Gerdelat-Mas [France] ; Fabienne Ory-Magne [France] ; Laure Pourcel [France] ; Monique Galitzky [France] ; Fabienne Calvas [France] ; Marion Simonetta-Moreau [France] ; Claire Thalamas [France] ; Pierre Payoux [France] ; Christine Brefel-Courbon [France] | Apomorphine effect on pain threshold in Parkinson's disease: A clinical and positron emission tomography study |
| 000180 |
Albert F. G. Leentjens [Pays-Bas] ; Kathy Dujardin [France] ; Laura Marsh [États-Unis] ; Irene H. Richard [États-Unis] ; Sergio E. Starkstein [Australie] ; Pablo Martinez-Martin [Espagne] | Anxiety rating scales in Parkinson's disease: A validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale |
| 000189 |
Gilles Fénelon [France] ; Thierry Soulas [France] ; Franck Zenasni [France] ; Laurent Cleret De Langavant [France] | The changing face of Parkinson's disease‐associated psychosis: A cross‐sectional study based on the new NINDS‐NIMH criteria |
| 000190 |
Carlo Colosimo [Italie] ; Pablo Martínez-Martín [Espagne] ; Giovanni Fabbrini [Italie] ; Robert A. Hauser [États-Unis] ; Marcelo Merello [Argentine] ; Janis Miyasaki [Canada] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Olivier Rascol [France] ; Glenn T. Stebbins [États-Unis] ; Anette Schrag [Royaume-Uni] ; Christopher G. Goetz [États-Unis] | Task force report on scales to assess dyskinesia in Parkinson's disease: Critique and recommendations |
| 000192 |
Jerrold L. Vitek [États-Unis] ; Kelly E. Lyons [États-Unis] ; Roy Bakay [États-Unis] ; Alim-Louis Benabid [France] ; Guenther Deuschl [Allemagne] ; Mark Hallett [États-Unis] ; Roger Kurlan [États-Unis] ; Joseph J. Pancrazio [États-Unis] ; Ali Rezai [États-Unis] ; Benjamin L. Walter [États-Unis] ; Anthony E. Lang [Canada] | Standard guidelines for publication of deep brain stimulation studies in Parkinson's disease (Guide4DBS‐PD) |
| 000194 |
Joaquim J. Ferreira [Portugal] ; Dulce Neutel [Portugal] ; Tiago Mestre [Portugal] ; Miguel Coelho [Portugal] ; Mário M. Rosa [Portugal] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] | Skin cancer and Parkinson's disease |
| 000197 |
Birgit Högl [Autriche] ; Isabelle Arnulf [France] ; Cynthia Comella [États-Unis] ; Joaquim Ferreira [Portugal] ; Alex Iranzo [Espagne] ; Barbara Tilley [États-Unis] ; Claudia Trenkwalder [Allemagne] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Glenn T. Stebbins [États-Unis] ; Anette Schrag [Royaume-Uni] ; Christopher G. Goetz [États-Unis] | Scales to assess sleep impairment in Parkinson's disease: Critique and recommendations |
| 000198 |
Karla Eggert [Allemagne] ; David Squillacote [États-Unis] ; Paolo Barone [Italie] ; Richard Dodel [Allemagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Olivier Rascol [France] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Claudia Trenkwalder [Allemagne] ; Marco Onofrj [Italie] ; Fabrizio Stocchi [Italie] ; Giuseppe Nappi [Italie] ; Vladimir Kostic [Serbie] ; Jagoda Potic [Serbie] ; Evzen Ruzicka [République tchèque] ; Wolfgang Oertel [Allemagne] | Safety and efficacy of perampanel in advanced Parkinson's disease: A randomized, placebo‐controlled study |
| 000199 |
Anthony H. V. Schapira [Royaume-Uni] ; Stefan Albrecht [Allemagne] ; Paolo Barone [Italie] ; Cynthia L. Comella [États-Unis] ; Michael P. Mcdermott [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Kenneth Marek [États-Unis] | Rationale for delayed‐start study of pramipexole in Parkinson's disease: The PROUD study |
| 000200 |
Robert A. Hauser [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Olivier Rascol [France] ; Paolo Barone [Italie] ; Yoshikuni Mizuno [Japon] ; Laurence Salin [France] ; Monika Haaksma [Autriche] ; Nolwenn Juhel [France] ; Werner Poewe [Autriche] | Randomized, double‐blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease |
| 000204 |
Kathy Dujardin [France] ; Bruno Dubois [France] ; François Tison [France] ; Franck Durif [France] ; Isabelle Bourdeix [France] ; Jean-Jacques Péré [France] ; Alain Duhamel [France] | Parkinson's disease dementia can be easily detected in routine clinical practice |
| 000205 |
Tiphaine Rouaud [France] ; Thibaut Dondaine [France] ; Sophie Drapier [France] ; Claire Haegelen [France] ; François Lallement [France] ; Julie Péron [France] ; Sylvie Raoul [France] ; Paul Sauleau [France] ; Marc Vérin [France] | Pallidal stimulation in advanced Parkinson's patients with contraindications for subthalamic stimulation |
| 000206 |
Olivier Rascol [France] ; Jean-Philippe Azulay [France] ; Olivier Blin [France] ; Anne-Marie Bonnet [France] ; Christine Brefel-Courbon [France] ; Pierre Césaro [France] ; Philippe Damier [France] ; Bérengère Debilly [France] ; Frank Durif [France] ; Monique Galitzky [France] ; Jean-Marie Grouin [France] ; Sylvie Pennaforte [France] ; Gabriel Villafane [France] ; Sadek Yaici [France] ; Yves Agid [France] | Orodispersible sublingual piribedil to abort OFF episodes: A single dose placebo‐controlled, randomized, double‐blind, cross‐over study |
| 000207 |
Arnaud Delval [France, Pays-Bas] ; Anke H. Snijders [Pays-Bas] ; Vivian Weerdesteyn [Pays-Bas] ; Jacques E. Duysens [Pays-Bas] ; Luc Defebvre [France] ; Nir Giladi [Israël] ; Bastiaan R. Bloem [Pays-Bas] | Objective detection of subtle freezing of gait episodes in Parkinson's disease |
| 000209 |
Elena Moro [Canada] ; Andres M. Lozano [Canada] ; Pierre Pollak [France] ; Yves Agid [France] ; Stig Rehncrona [Suède] ; Jens Volkmann [Allemagne] ; Jaime Kulisevsky [Espagne] ; Jose A. Obeso [Espagne] ; Alberto Albanese [Italie] ; Marwan I. Hariz [Royaume-Uni, Suède] ; Niall P. Quinn [Royaume-Uni] ; Jans D. Speelman [Pays-Bas] ; Alim-Louis Benabid [France] ; Valerie Fraix [France] ; Alexandre Mendes [France] ; Marie-Laure Welter [France] ; Jean-Luc Houeto [France] ; Philippe Cornu [France] ; Didier Dormont [France] ; Annalena L. Tornqvist [Suède] ; Ron Ekberg [Suède] ; Alfons Schnitzler [Allemagne] ; Lars Timmermann [Allemagne] ; Lars Wojtecki [Allemagne] ; Andres Gironell [Espagne] ; Maria C. Rodriguez-Oroz [Espagne] ; Jorge Guridi [Espagne] ; Anna R. Bentivoglio [Italie] ; Maria F. Contarino [Italie, Pays-Bas] ; Luigi Romito [Italie] ; Massimo Scerrati [Italie] ; Marc Janssens [Pays-Bas] ; Anthony E. Lang [Canada] | Long‐term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease |
| 000216 |
Joseph H. Friedman [États-Unis] ; Guido Alves [Norvège] ; Peter Hagell [Suède] ; Johan Marinus [Pays-Bas] ; Laura Marsh [États-Unis] ; Pablo Martinez-Martin [Espagne] ; Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Glenn Stebbins [États-Unis] ; Anette Schrag [Royaume-Uni] | Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease |
| 000217 |
Olivier Rascol [France] ; Paolo Barone [Italie] ; Robert A. Hauser [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Anthony H. V. Schapira [Royaume-Uni] ; Laurence Salin [France] ; Mandy Sohr [Allemagne] ; Catherine Debieuvre [France] | Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease |
| 000219 |
Juliana Bronzova [Pays-Bas] ; Cristina Sampaio [Portugal] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Ad Theeuwes [Pays-Bas] ; Serge V. Van De Witte [Pays-Bas] ; Guus Van Scharrenburg [Pays-Bas] | Double‐blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease |
| 000222 |
Laurence Nègre-Pagès [France] ; Hélène Grandjean [France] ; Maryse Lapeyre-Mestre [France] ; Jean Louis Montastruc [France] ; Annie Fourrier [France] ; Jean Pierre Lépine [France] ; Olivier Rascol [France] | Anxious and depressive symptoms in Parkinson's disease: The French cross‐sectionnal DoPaMiP study |
| 000225 |
François Vacherot [France] ; Shahram Attarian [France] ; Marianne Vaugoyeau [France] ; Jean-Philippe Azulay [France] | A motor cortex excitability and gait analysis on Parkinsonian patients |
| 000231 |
Nir Giladi [Israël] ; Joseph Tal [Israël] ; Tali Azulay [Israël] ; Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Eldad Melamed [Israël] ; Wolfgang Oertel [Allemagne] ; Werner Poewe [Autriche] ; Fabrizio Stocchi [Italie] ; Eduardo Tolosa [Espagne] | Validation of the freezing of gait questionnaire in patients with Parkinson's disease |
| 000236 |
Nadège Limousin [France] ; Eric Konofal [France] ; Elias Karroum [France] ; Ebba Lohmann [France] ; Ioannis Theodorou [France] ; Alexandra Dürr [France] ; Isabelle Arnulf [France] | Restless legs syndrome, rapid eye movement sleep behavior disorder, and hypersomnia in patients with two parkin mutations |
| 000239 |
Sophie Lavault [France] ; Frederic Bloch [France] ; Jean-Luc Houeto [France] ; Eric Konofal [France] ; Marie-Laure Welter [France] ; Yves Agid [France] ; Isabelle Arnulf [France] | Periodic leg movements and REM sleep without atonia in Parkinson's disease with camptocormia |
| 000240 |
David Devos [France] | Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease |
| 000241 |
Ichraf Kraoua [France] ; Jérôme Stirnemann [France] ; Maria João Ribeiro [France] ; Tiphaine Rouaud [France] ; Marc Verin [France] ; Agnès Annic [France] ; Christian Rose [France] ; Luc Defebvre [France] ; Liliane Réménieras [France] ; Michaël Schüpbach [France] ; Nadia Belmatoug [France] ; Marie Vidailhet [France] ; Frédéric Sedel [France] | Parkinsonism in Gaucher's disease type 1: Ten new cases and a review of the literature |
| 000246 |
Mélissa Tir [France] ; Christine Delmaire [France] ; Vianney Le Thuc [France] ; Alain Duhamel [France] ; Alain Destée [France] ; Jean-Pierre Pruvo [France] ; Luc Defebvre [France] | Motor‐related circuit dysfunction in MSA‐P: Usefulness of combined whole‐brain imaging analysis |
| 000247 |
David Maltête [France] ; Nathalie Chastan [France] ; Stéphane Derrey [France] ; Bertrand Debono [France] ; Emmanuel Gérardin [France] ; Romain Lefaucheur [France] ; Bruno Mihout [France] ; Didier Hannequin [France] | Microsubthalamotomy effect at day 3: Screening for determinants |
| 000252 |
Nathalie Chastan [France] ; Manh Cuong Do [France] ; Fabrice Bonneville [France] ; Frédéric Torny [France] ; Frédéric Bloch [France] ; G. W. Max Westby [France] ; Didier Dormont [France] ; Yves Agid [France] ; Marie-Laure Welter [France] | Gait and balance disorders in Parkinson's disease: Impaired active braking of the fall of centre of gravity |
| 000256 |
Marian L. Evatt [États-Unis] ; K. Ray Chaudhuri [Royaume-Uni] ; Kelvin L. Chou [États-Unis] ; Ester Cubo [Espagne] ; Vanessa Hinson [États-Unis] ; Katie Kompoliti [États-Unis] ; Chengwu Yang [États-Unis] ; Werner Poewe [États-Unis] ; Olivier Rascol [Autriche] ; Cristina Sampaio [France, Portugal] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] | Dysautonomia rating scales in Parkinson's disease: Sialorrhea, dysphagia, and constipation—Critique and recommendations by movement disorders task force on rating scales for Parkinson's disease |
| 000260 |
Paul Sauleau [France] ; Emmanuelle Leray [France] ; Tiphaine Rouaud [France] ; Sophie Drapier [France] ; Dominique Drapier [France] ; Sophie Blanchard [France] ; Gwenolla Drillet [France] ; Julie Péron [France] ; Marc Vérin [France] | Comparison of weight gain and energy intake after subthalamic versus pallidal stimulation in Parkinson's disease |
| 000261 |
Gabriel Robert [France] ; Dominique Drapier [France] ; Marc Verin [France] ; Bruno Millet [France] ; Jean-Philippe Azulay [France] ; Olivier Blin [France] | Cognitive impulsivity in Parkinson's disease patients: Assessment and pathophysiology |
| 000263 |
Karim Farid [France] ; Igor Sibon [France] ; Dominique Guehl [France] ; Emmanuel Cuny [France] ; Pierre Burbaud [France] ; Michèle Allard [France] | Brain dopaminergic modulation associated with executive function in Parkinson's disease |
| 000267 |
Donald Grosset [Royaume-Uni] ; Angelo Antonini [Italie] ; Margherita Canesi [Italie] ; Gianni Pezzoli [Italie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Karen Shaw [Royaume-Uni] ; Esther Cubo [Espagne] ; Pablo Martinez-Martin [Espagne] ; Olivier Rascol [France] ; Laurence Negre-Pages [France] ; Ana Senard [France] ; Johannes Schwarz [Allemagne] ; Karl Strecker [Allemagne] ; Heinz Reichmann [Allemagne] ; Alexander Storch [Allemagne] ; Matthias Löhle [Allemagne] ; Fabrizio Stocchi [Italie] ; Katherine Grosset [Royaume-Uni] | Adherence to antiparkinson medication in a multicenter European study |
| 000268 |
Olivier Rascol [France] ; Ludwig Schelosky [Suisse] | 123I‐metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders |
| 000272 |
Sébastien Montel [France] ; Catherine Bungener [France] | What relation is there between deep brain stimulation and coping strategies in Parkinson's disease? |
| 000276 |
Kathy Dujardin [France] ; Pascal Sockeel [France] ; Marie Delliaux [France] ; Alain Destée [France] ; Luc Defebvre [France] | The Lille Apathy Rating Scale: Validation of a caregiver‐based version |
| 000285 |
Christopher G. Goetz [États-Unis] ; Eugene Laska [États-Unis] ; Christine Hicking [Allemagne] ; Philippe Damier [France] ; Thomas Müller [Allemagne] ; John Nutt [États-Unis] ; C. Warren Olanow [États-Unis] ; Olivier Rascol [France] ; Hermann Russ [Allemagne] | Placebo influences on dyskinesia in Parkinson's disease |
| 000286 |
Christopher G. Goetz [États-Unis] ; Barbara C. Tilley [États-Unis] ; Stephanie R. Shaftman [États-Unis] ; Glenn T. Stebbins [États-Unis] ; Stanley Fahn [États-Unis] ; Pablo Martinez-Martin [Espagne] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Matthew B. Stern [États-Unis] ; Richard Dodel [Allemagne] ; Bruno Dubois [France] ; Robert Holloway [États-Unis] ; Joseph Jankovic [États-Unis] ; Jaime Kulisevsky [Espagne] ; Anthony E. Lang [Canada] ; Andrew Lees (neurologue) [Royaume-Uni] ; Sue Leurgans [États-Unis] ; Peter A. Lewitt [États-Unis] ; David Nyenhuis [États-Unis] ; C. Warren Olanow [États-Unis] ; Olivier Rascol [France] ; Anette Schrag [Royaume-Uni] ; Jeanne A. Teresi [États-Unis] ; Jacobus J. Van Hilten [Pays-Bas] ; Nancy Lapelle [États-Unis] | Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results |
| 000294 |
Jean-Marc Trocello [France] ; Paolo Zanotti-Fregonara [France] ; Emmanuel Roze [France] ; Emmanuelle Apartis [France] ; André-Pierre Legrand [France] ; Marie-Odile Habert [France] ; Jean-Yves Devaux [France] ; Marie Vidailhet [France] | Dopaminergic deficit is not the rule in orthostatic tremor |
| 000295 |
Nathalie Chastan [France] ; Bertrand Debono [France] ; David Maltête [France] ; Jacques Weber [France] | Discordance between measured postural instability and absence of clinical symptoms in Parkinson's disease patients in the early stages of the disease |
| 000298 |
David Devos [France] ; Kathy Dujardin [France] ; Isabelle Poirot [France] ; Caroline Moreau [France] ; Olivier Cottencin [France] ; Pierre Thomas [France] ; Alain Destée [France] ; Regis Bordet [France] ; Luc Defebvre [France] | Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study |
| 000305 |
Albert F. G. Leentjens [Pays-Bas] ; Kathy Dujardin [France] ; Laura Marsh [États-Unis] ; Pablo Martinez-Martin [Espagne] ; Irene H. Richard [États-Unis] ; Sergio E. Starkstein [Australie] ; Daniel Weintraub [États-Unis] ; Cristina Sampaio [Portugal] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] | Apathy and anhedonia rating scales in Parkinson's disease: Critique and recommendations |
| 000306 |
Albert F. G. Leentjens [Pays-Bas] ; Kathy Dujardin [France] ; Laura Marsh [États-Unis] ; Pablo Martinez-Martin [Espagne] ; Irene H. Richard [États-Unis] ; Sergio E. Starkstein [Australie] ; Daniel Weintraub [États-Unis] ; Christina Sampaio [Portugal] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] | Anxiety rating scales in Parkinson's disease: Critique and recommendations |
| 000308 |
C. Warren Olanow [États-Unis] ; Robert A. Hauser [États-Unis] ; Joseph Jankovic [États-Unis] ; William Langston [États-Unis] ; Anthony Lang [Canada] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Fabrizio Stocchi [Italie] ; Eldad Melamed [Israël] ; Eli Eyal [Israël] ; Olivier Rascol [France] | A randomized, double‐blind, placebo‐controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics |
| 000314 |
Robert A. Hauser [États-Unis] ; Olivier Rascol [France] ; Amos D. Korczyn [Israël] ; A. Jon Stoessl [Canada] ; Ray L. Watts [États-Unis] ; Werner Poewe [Autriche] ; Peter P. De Deyn [Belgique] ; Anthony E. Lang [Canada] | Ten‐year follow‐up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa |
| 000316 |
Joaquim Ferreira [Portugal] ; João Maia Silva [Portugal] ; Rita Freire [Portugal] ; João Pignatelli [Portugal] ; Leonor Correia Guedes [Portugal] ; Alexandra Feij [Portugal] ; Mário Miguel Rosa [Portugal] ; Miguel Coelho [Portugal] ; João Costa [Portugal] ; Ana Noronha [Portugal] ; Russell Hewett [Portugal] ; A. Marques Gomes [Portugal] ; J. L. Cirne De Castro [Portugal] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] | Skin cancers and precancerous lesions in Parkinson's disease patients |
| 000317 |
Christopher G. Goetz [États-Unis] ; Philippe Damier [France] ; Christine Hicking [Allemagne] ; Eugene Laska [États-Unis] ; Thomas Müller [Allemagne] ; C. Warren Olanow [États-Unis] ; Olivier Rascol [France] ; Hermann Russ [Allemagne] | Sarizotan as a treatment for dyskinesias in Parkinson's disease: A double‐blind placebo‐controlled trial |
| 000321 |
Vincent Paillé [France] ; Vincent Henry [France] ; Laurent Lescaudron [France] ; Philippe Brachet [France] ; Philippe Damier [France] | Rat model of Parkinson's disease with bilateral motor abnormalities, reversible with levodopa, and dyskinesias |
| 000322 |
Robert A. Hauser [États-Unis] ; Laurence Salin [France] ; Nolwenn Juhel [France] ; Victor L. Konyago [États-Unis] | Randomized trial of the triple monoamine reuptake inhibitor NS 2330 (tesofensine) in early Parkinson's disease |
| 000325 |
Caroline Moreau [France] ; Canan Ozsancak [France] ; Jean-Louis Blatt [France] ; Philippe Derambure [France] ; Alain Destée [France] ; Luc Defebvre [France] | Oral festination in Parkinson's disease: Biomechanical analysis and correlation with festination and freezing of gait |
| 000326 |
Smaranda Leu-Semenescu [France] ; Emmanuel Roze [France] ; Marie Vidailhet [France] ; André-Pierre Legrand [France] ; Jean-Marc Trocello [France] ; Valérie Cochen [France] ; Sophie Sangla [France] ; Emmanuelle Apartis [France] | Myoclonus or tremor in orthostatism: An under‐recognized cause of unsteadiness in Parkinson's disease |
| 000327 |
Christopher G. Goetz [États-Unis] ; Stanley Fahn [États-Unis] ; Pablo Martinez-Martin [Espagne] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Glenn T. Stebbins [États-Unis] ; Matthew B. Stern [États-Unis] ; Barbara C. Tilley [États-Unis] ; Richard Dodel [Allemagne] ; Bruno Dubois [France] ; Robert Holloway [États-Unis] ; Joseph Jankovic [États-Unis] ; Jaime Kulisevsky [Espagne] ; Anthony E. Lang [Canada] ; Andrew Lees (neurologue) [Royaume-Uni] ; Sue Leurgans [États-Unis] ; Peter A. Lewitt [États-Unis] ; David Nyenhuis [États-Unis] ; C. Warren Olanow [États-Unis] ; Olivier Rascol [France] ; Anette Schrag [Royaume-Uni] ; Jeanne A. Teresi [États-Unis] ; Jacobus J. Van Hilten [Pays-Bas] ; Nancy Lapelle [États-Unis] | Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Process, format, and clinimetric testing plan |
| 000328 |
Michael W. M. Schüpbach [France] ; Marie Laure Welter [France] ; Anne Marie Bonnet [France] ; Alexis Elbaz [France] ; Brandon R. Grossardt [États-Unis] ; Valerie Mesnage [France] ; Jean Luc Houeto [France] ; David Maltête [France] ; Luc Mallet [France] ; Walter A. Rocca [États-Unis] ; Alain Mallet [France] ; Yves Agid [France] | Mortality in patients with Parkinson's disease treated by stimulation of the subthalamic nucleus |
| 000329 |
Mathieu Anheim [France] ; Valérie Fraix [France] ; Stéphan Chabardès [France] ; Paul Krack [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] | Lifetime of Itrel II pulse generators for subthalamic nucleus stimulation in Parkinson's disease |
| 000331 |
Walter A. Rocca [États-Unis] ; James H. Bower [États-Unis] ; J. Eric Ahlskog [États-Unis] ; Alexis Elbaz [États-Unis, France] ; Brandon R. Grossardt [États-Unis] ; Shannon K. Mcdonnell [États-Unis] ; Daniel J. Schaid [États-Unis] ; Demetrius M. Maraganore [États-Unis] | Increased risk of essential tremor in first‐degree relatives of patients with Parkinson's disease |
| 000338 |
Tatiana Witjas [France] ; Elsa Kaphan [France] ; Jean Régis [France] ; Elisabeth Jouve [France] ; André Ali Chérif [France] ; Jean-Claude Péragut [France] ; Jean Philippe Azulay [France] | Effects of chronic subthalamic stimulation on nonmotor fluctuations in Parkinson's disease |
| 000340 |
Bruno Dubois [France] ; David Burn [Royaume-Uni] ; Christopher Goetz [États-Unis] ; Dag Aarsland [Norvège] ; Richard G. Brown [Royaume-Uni] ; Gerald A. Broe [Australie] ; Dennis Dickson [États-Unis] ; Charles Duyckaerts [France] ; Jefferey Cummings [États-Unis] ; Serge Gauthier [Canada] ; Amos Korczyn [Israël] ; Andrew Lees (neurologue) [Royaume-Uni] ; Richard Levy [France] ; Irene Litvan [États-Unis] ; Yoshikuni Mizuno [Japon] ; Ian G. Mckeith [Royaume-Uni] ; C. Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Eduardo Tolosa [Espagne] ; Murat Emre [Turquie] | Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force |
| 000342 |
Anette Schrag [Royaume-Uni] ; Paolo Barone [Italie] ; Richard G. Brown [Royaume-Uni] ; Albert F. G. Leentjens [Pays-Bas] ; William M. Mcdonald [États-Unis] ; Sergio Starkstein [Australie] ; Daniel Weintraub [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] | Depression rating scales in Parkinson's disease: Critique and recommendations |
| 000343 |
Emmanuel Broussolle [France] ; Paul Krack [France] ; Stéphane Thobois [France] ; Jing Xie-Brustolin [France] ; Pierre Pollak [France] ; Christopher G. Goetz [États-Unis] | Contribution of Jules Froment to the study of Parkinsonian rigidity |
| 000344 |
Paul Sauleau [France] ; Pierre Pollak [France] ; Paul Krack [France] ; Denis Pélisson [France] ; Alain Vighetto [France] ; Alim-Louis Benabid [France] ; Caroline Tilikete [France] | Contraversive eye deviation during stimulation of the subthalamic region |
| 000346 |
Murat Emre [Turquie] ; Dag Aarsland [Norvège] ; Richard Brown [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Charles Duyckaerts [France] ; Yoshikino Mizuno [Japon] ; Gerald Anthony Broe [Australie] ; Jeffrey Cummings [États-Unis] ; Dennis W. Dickson [États-Unis] ; Serge Gauthier [Canada] ; Jennifer Goldman [États-Unis] ; Christopher Goetz [États-Unis] ; Amos Korczyn [Israël] ; Andrew Lees (neurologue) [Royaume-Uni] ; Richard Levy [France] ; Irene Litvan [États-Unis] ; Ian Mckeith [Royaume-Uni] ; Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; Christina Sampaio [Portugal] ; Eduardo Tolosa [Espagne] ; Bruno Dubois [France] | Clinical diagnostic criteria for dementia associated with Parkinson's disease |
| 000349 |
Imad Ghorayeb [France] ; Anderson Loundou [France] ; Pascal Auquier [France] ; Yves Dauvilliers [France] ; Bernard Bioulac [France] ; François Tison [France] | A nationwide survey of excessive daytime sleepiness in Parkinson's disease in France |
| 000353 |
Alexandre Castro-Caldas [Portugal] ; Paul Delwaide [Belgique] ; Wolfgang Jost [Allemagne] ; Marcelo Merello [Argentine] ; Adrian Williams [Royaume-Uni] ; Paolo Lamberti [Italie] ; Miguel Aguilar [Espagne] ; Susanna Del Signore [France] ; Pierre Cesaro [France] | The Parkinson–Control study: A 1‐year randomized, double‐blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease |
| 000356 |
Sandrine Benaderette [France] ; Paolo Zanotti Fregonara [France] ; Emmanuelle Apartis [France] ; Charles Nguyen [France] ; Jean-Marc Trocello [France] ; Philippe Remy [France] ; Jean-Yves Devaux [France] ; Serge Askienazy [France] ; Marie Vidailhet [France] | Psychogenic parkinsonism: A combination of clinical, electrophysiological, and [123I]‐FP‐CIT SPECT scan explorations improves diagnostic accuracy |
| 000357 |
Wolfgang H. Oertel [Allemagne] ; Erik Wolters [Pays-Bas] ; Cristina Sampaio [Portugal] ; Santiago Gimenez-Roldan [Espagne] ; Bruno Bergamasco [Italie] ; Max Dujardin [France] ; Donald G. Grosset [Royaume-Uni] ; Guy Arnold [Allemagne] ; Klaus L. Leenders [Pays-Bas] ; Hans-Peter Hundemer [États-Unis] ; Alberto Lled [États-Unis] ; Andrew Wood [États-Unis] ; Paul Frewer [États-Unis] ; Johannes Schwarz [Allemagne] | Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study |
| 000358 |
Claire Ardouin [France] ; Valerie Voon [Canada] ; Yulia Worbe [France] ; Nehman Abouazar [France] ; Virginie Czernecki [France] ; Hassan Hosseini [France] ; Antoine Pelissolo [France] ; Elena Moro [Canada] ; Eugénie Lhommée [France] ; Anthony E. Lang [Canada] ; Yves Agid [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] ; Luc Mallet [France] ; Paul Krack [France] | Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation |
| 000364 |
Emmanuel Roze [France] ; Maria Clara Coêlho-Braga [France] ; Dominique Gayraud [France] ; André Pierre Legrand [France] ; Jean-Marc Trocello [France] ; Gilles Fénelon [France] ; Valérie Cochen [France] ; Nathalie Patte [France] ; François Viallet [France] ; Marie Vidailhet [France] ; Pierre Pollak [France] ; Emmanuelle Apartis [France] | Head tremor in Parkinson's disease |
| 000368 |
Aurélie Funkiewiez [France] ; Claire Ardouin [France] ; Roshan Cools [Royaume-Uni] ; Paul Krack [France] ; Valérie Fraix [France] ; Alina Batir [France] ; Stephan Chabardès [France] ; Alim-Louis Benabid [France] ; Trevor W. Robbins [Royaume-Uni] ; Pierre Pollak [France] | Effects of levodopa and subthalamic nucleus stimulation on cognitive and affective functioning in Parkinson's disease |
| 000369 |
Olivier Rascol [France] ; Bruno Dubois [France] ; Alexandre Castro Caldas [Portugal] ; Stephen Senn [Royaume-Uni] ; Susanna Del Signore [France] ; Andrew Lees (neurologue) [Royaume-Uni] | Early piribedil monotherapy of Parkinson's disease: A planned seven‐month report of the REGAIN study |
| 000371 |
Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Amos D. Korczyn [Israël] ; Peter P. De Deyn [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Anthony E. Lang [Canada] ; Mona Abdalla [Royaume-Uni] | Development of dyskinesias in a 5‐year trial of ropinirole and L‐dopa |
| 000374 |
Anthony E. Lang [Canada] ; Jean-Luc Houeto [France] ; Paul Krack [France] ; Cynthia Kubu [États-Unis] ; Kelly E. Lyons [États-Unis] ; Elena Moro [Canada] ; William Ondo [États-Unis] ; Rajesh Pahwa [États-Unis] ; Werner Poewe [Autriche] ; Alexander I. Tröster [États-Unis] ; Ryan Uitti [États-Unis] ; Valerie Voon [Canada, États-Unis] | Deep brain stimulation: Preoperative issues |
| 000375 |
Valerie Voon [Canada, États-Unis] ; Cynthia Kubu [États-Unis] ; Paul Krack [France] ; Jean-Luc Houeto [France] ; Alexander I. Tröster [États-Unis] | Deep brain stimulation: Neuropsychological and neuropsychiatric issues |
| 000377 |
Andre Machado [États-Unis] ; Ali R. Rezai [États-Unis] ; Brian H. Kopell [États-Unis] ; Robert E. Gross [États-Unis] ; Ashwini D. Sharan [États-Unis] ; Alim-Louis Benabid [France] | Deep brain stimulation for Parkinson's disease: Surgical technique and perioperative management |
| 000378 |
Ali R. Rezai [États-Unis] ; Brian H. Kopell [États-Unis] ; Robert E. Gross [États-Unis] ; Jerrold L. Vitek [États-Unis] ; Ashwini D. Sharan [États-Unis] ; Patricia Limousin [Royaume-Uni] ; Alim-Louis Benabid [France] | Deep brain stimulation for Parkinson's disease: Surgical issues |
| 000381 |
Roberta Frigerio [États-Unis] ; Kevin R. Sanft [États-Unis] ; Brandon R. Grossardt [États-Unis] ; Brett J. Peterson [États-Unis] ; Alexis Elbaz [France] ; James H. Bower [États-Unis] ; J. Eric Ahlskog [États-Unis] ; Mariza De Andrade [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Walter A. Rocca [États-Unis] | Chemical exposures and Parkinson's disease: A population‐based case–control study |
| 000383 |
Michael P. Hill [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni] ; Steven G. Mcguire [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni, Canada] ; Alan R. Crossman [Royaume-Uni] ; Catherine Rochat [France] ; Mark J. Millan [France] | Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP‐lesioned marmosets: Mediation by D2, not D3, dopamine receptors |
| 000395 |
Alexis Elbaz [États-Unis, France] ; Brett J. Peterson [États-Unis] ; James H. Bower [États-Unis] ; Ping Yang [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Shannon K. Mcdonnell [États-Unis] ; J. Eric Ahlskog [États-Unis] ; Walter A. Rocca [États-Unis] | Risk of cancer after the diagnosis of Parkinson's disease: A historical cohort study |
| 000397 |
Pierre Champy [France] ; Alice Melot [France] ; Vincent Guérineau Eng [France] ; Christophe Gleye [France] ; Djibril Fall [France, Sénégal] ; Gunter U. Höglinger [France] ; Merle Ruberg [France] ; Annie Lannuzel [France] ; Olivier Laprévote [France] ; Alain Laurens [France] ; Reynald Hocquemiller [France] | Quantification of acetogenins in Annona muricata linked to atypical parkinsonism in guadeloupe |
| 000400 |
Stéphane Chapuis [France] ; Lemlih Ouchchane [France] ; Olivier Metz [France] ; Laurent Gerbaud [France] ; Franck Durif [France] | Impact of the motor complications of Parkinson's disease on the quality of life |
| 000402 |
Anne Doé De Maindreville [France] ; Gilles Fénelon [France] ; Florence Mahieux [France] | Hallucinations in Parkinson's disease: A follow‐up study |
| 000404 |
Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] | Evidence‐based medical review update: Pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004 |
| 000406 |
Nicolas Simon [France] ; Joëlle Micallef [France] ; Jean-Charles Reynier [France] ; Monique Lesourd [France] ; Tatiana Witjas [France] ; André Alicherif [France] ; Jean-Philippe Azulay [France] ; Olivier Blin [France] | End‐of‐dose akinesia after a single intravenous infusion of the dopaminergic agonist piribedil in Parkinson's disease patients: A pharmacokinetic/pharmacodynamic, randomized, double‐blind study |
| 000407 |
Christine Brefel-Courbon [France] ; Pierre Payoux [France] ; Claire Thalamas [France] ; Fabienne Ory [France] ; Isabelle Quelven [France] ; François Chollet [France] ; Jean Louis Montastruc [France] ; Olivier Rascol [France] | Effect of levodopa on pain threshold in Parkinson's disease: A clinical and positron emission tomography study |
| 000409 |
Alexandre Kreisler [France] ; Luc Defebvre [France] ; Pascal Lecouffe [France] ; Alain Duhamel [France] ; Pierre Charpentier [France] ; Marc Steinling [France] ; Alain Destée [France] | Corticobasal degeneration and Parkinson's disease assessed by HmPaO SPECT: The utility of factorial discriminant analysis |
| 000412 |
Jean-Philippe Galanaud [France] ; Alexis Elbaz [France] ; Jacqueline Clavel [France] ; Jean-Sébastien Vidal [France] ; Jean-René Corrèze [France] ; Annick Alpérovitch [France] ; Christophe Tzourio [France] | Cigarette smoking and Parkinson's disease: A case–control study in a population characterized by a high prevalence of pesticide exposure |
| 000413 |
Anne Beuter [France] ; Emilie Barbo [Canada] ; Robert Rigal [Canada] ; Pierre J. Blanchet [Canada] | Characterization of subclinical tremor in Parkinson's disease |
| 000414 |
Serge Pinto [France, Royaume-Uni] ; Michèle Gentil [France] ; Paul Krack [France] ; Paul Sauleau [France] ; Valérie Fraix [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] | Changes induced by levodopa and subthalamic nucleus stimulation on parkinsonian speech |
| 000424 |
Jan C. M. Zijlmans [Royaume-Uni, Pays-Bas] ; Berengere Debilly [France] ; Olivier Rascol [France] ; Andrew Lees (neurologue) [Royaume-Uni] ; Franck Durif [France] | Safety of entacapone and apomorphine coadministration in levodopa‐treated Parkinson's disease patients: Pharmacokinetic and pharmacodynamic results of a multicenter, double‐blind, placebo‐controlled, cross‐over study |
| 000427 |
Jasmine Henderson [Australie] ; Michael Rodriguez [Australie] ; Dudley O'Sullivan [Australie] ; Malcolm Pell [Australie] ; Victor Fung [Australie] ; Alim-Louis Benabid [Australie, France] ; Glenda Halliday [Australie] | Partial lesion of thalamic ventral intermediate nucleus after chronic high‐frequency stimulation |
| 000428 |
Frédéric Macia [France] ; Caroline Perlemoine [France] ; Irène Coman [France] ; Dominique Guehl [France] ; Pierre Burbaud [France] ; Emmanuel Cuny [France] ; Henri Gin [France] ; Vincent Rigalleau [France] ; François Tison [France] | Parkinson's disease patients with bilateral subthalamic deep brain stimulation gain weight |
| 000431 |
Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Royaume-Uni] ; Glenn T. Stebbins [États-Unis] ; Carl Counsell [Portugal] ; Nir Giladi [Israël] ; Robert G. Holloway [États-Unis] ; Charity G. Moore [États-Unis] ; Gregor K. Wenning [Autriche] ; Melvin D. Yahr [États-Unis] ; Lisa Seidl [États-Unis] | Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease |
| 000432 |
C. Warren Olanow [États-Unis] ; Yves Agid [France] ; Yoshi Mizuno [Japon] ; Alberto Albanese [Italie] ; U. Bonucelli [Italie] ; Philip Damier [France] ; Justo De Yebenes [Espagne] ; Oscar Gershanik [Argentine] ; Mark Guttman [Canada] ; F. Grandas [Espagne] ; Mark Hallett [États-Unis] ; Ole Hornykiewicz [Autriche] ; Peter Jenner [Royaume-Uni] ; R. Katzenschlager [Royaume-Uni] ; William J. Langston [États-Unis] ; Peter Lewitt [États-Unis] ; Eldad Melamed [Israël] ; M. A. Mena [Espagne] ; P. P. Michel [France] ; Catherine Mytilineou [États-Unis] ; Jose A. Obeso [Espagne] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; R. Raisman-Vozari [France] ; Ali H. Rajput [Canada] ; Olivier Rascol [France] ; Christina Sampaio [Portugal] ; Fabrizio Stocchi [Italie] | Levodopa in the treatment of Parkinson's disease: Current controversies |
| 000446 |
Thomas Gasser [Allemagne] ; Susan Bressman [États-Unis] ; Alexandra Dürr [France] ; Joseph Higgins [États-Unis] ; Thomas Klockgether [Allemagne] ; Richard H. Myers [États-Unis] | State of the art review: Molecular diagnosis of inherited movement disorders. Movement Disorders Society task force on molecular diagnosis |
| 000447 |
Sylvie Raoul [France] ; Mirella Faighel [France] ; Isabelle Rivier [France] ; Marc Vérin [France] ; Youenn Lajat [France] ; Philippe Damier [France] | Staged lesions through implanted deep brain stimulating electrodes: A new surgical procedure for treating tremor or dyskinesias |
| 000448 |
Alexis Elbaz [France] ; Clotilde Levecque [France] ; Jacqueline Clavel [France] ; Jean-Sébastien Vidal [France] ; Florence Richard [France] ; Jean-René Corrèze [France] ; Bernard Delemotte [France] ; Philippe Amouyel [France] ; Annick Alpérovitch [France] ; Marie-Christine Chartier-Harlin [France] ; Christophe Tzourio [France] | S18Y polymorphism in the UCH‐L1 gene and Parkinson's disease: Evidence for an age‐dependent relationship |
| 000449 |
Bechir Jarraya [France] ; Anne-Marie Bonnet [France] ; Charles Duyckaerts [France] ; Jean-Luc Houeto [France] ; Philippe Cornu [France] ; Jean-Jacques Hauw [France] ; Yves Agid [France] | Parkinson's disease, subthalamic stimulation, and selection of candidates: A pathological study |
| 000455 |
Marc Ziegler ; Alexandre Castro-Caldas [Portugal] ; Susanna Del Signore [France] ; Olivier Rascol [France] | Efficacy of piribedil as early combination to levodopa in patients with stable Parkinson's disease: A 6‐month, randomized, placebo‐controlled study |
| 000457 |
Christine Brefel-Courbon [France] ; Karine Desboeuf [France] ; Claire Thalamas [France] ; Monique Galitzky [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France] | Clinical and economic analysis of spa therapy in Parkinson's disease |
| 000458 |
Frédéric Courbon [France] ; Christine Brefel-Courbon [France] ; Claire Thalamas [France] ; Marie Jeanne Alibelli [France] ; Isabelle Berry [France] ; Jean-Louis Montastruc [France] ; Olivier Rascol [France] ; Jean-Michel Senard [France] | Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease |
| 000460 |
Aurélie Funkiewiez [France] ; Claire Ardouin [France] ; Paul Krack [France] ; Valérie Fraix [France] ; Nadège Van Blercom [France] ; Jing Xie [France] ; Elena Moro [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] | Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease |
| 000461 |
Philippe Le Cavorzin [France] ; Guy Carrault [France] ; Francis Chagneau [France] ; Pierre Rochcongar [France] ; Hervé Allain [France] | A computer model of rigidity and related motor dysfunction in Parkinson's disease |
| 000464 |
Pierre Pollak [France] ; Valérie Fraix [France] ; Paul Krack [France] ; Elena Moro [France] ; Alexandre Mendes [France] ; Stephan Chabardes [France] ; Adnan Koudsie [France] ; Alim-Louis Benabid [France] | Treatment results: Parkinson's disease |
| 000468 |
Lance A. Smith [Royaume-Uni] ; Banu C. Tel [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Matthew J. Hansard [Royaume-Uni] ; Rogelio Braceras [Royaume-Uni] ; Céline Bonhomme [France] ; Claire Chezaubernard [France] ; Susanna Del Signore [France] ; Sarah Rose [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | Repeated administration of piribedil induces less dyskinesia than L‐dopa in MPTP‐treated common marmosets: A behavioural and biochemical investigation |
| 000469 |
Marie Sarazin [France] ; Bernard Deweer [France] ; Angela Merkl [France] ; Natalia Von Poser [France] ; Bernard Pillon [France] ; Bruno Dubois [France] | Procedural learning and striatofrontal dysfunction in Parkinson's disease |
| 000470 |
Paul Krack [France] ; Valérie Fraix [France] ; Alexandre Mendes [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] | Postoperative management of subthalamic nucleus stimulation for Parkinson's disease |
| 000471 |
François Tison [France] ; Farid Yekhlef [France] ; Virginie Chrysostome [France] ; Eric Balestre [France] ; Niall P. Quinn [Royaume-Uni] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche] | Parkinsonism in multiple system atrophy: Natural history, severity (UPDRS‐III), and disability assessment compared with Parkinson's disease |
| 000474 |
Bernard Pillon [France] | Neuropsychological assessment for management of patients with deep brain stimulation |
| 000478 |
Franck Durif [France] ; Jean-Jacques Lemaire [France] ; Bérengère Debilly [France] ; Gérard Dordain [France] | Long‐Term follow‐up of globus pallidus chronic stimulation in advanced Parkinson's disease |
| 000480 |
Pierre Pollak [France] ; Paul Krack [France] ; Valérie Fraix [France] ; Alexandre Mendes [France] ; Elena Moro [France] ; Stephan Chabardes [France] ; Alim-Louis Benabid [France] | Intraoperative micro‐ and macrostimulation of the subthalamic nucleus in Parkinson's disease |
| 000481 |
Abdelhamid Benazzouz [France] ; Sorin Breit [France] ; Adnan Koudsie [France] ; Pierre Pollak [France] ; Paul Krack [France] ; Alim-Louis Benabid [France] | Intraoperative microrecordings of the subthalamic nucleus in Parkinson's disease |
| 000482 |
Luc J. P. Defebvre [France] ; Pierre Krystkowiak [France] ; Jean-Louis Blatt [France] ; Alain Duhamel [France] ; Jean-Louis Bourriez [France] ; Myriame Périna [France] ; Serge Blond [France] ; Jean-Daniel Guieu [France] ; Alain Destée [France] | Influence of pallidal stimulation and levodopa on gait and preparatory postural adjustments in Parkinson's disease |
| 000503 |
Oum-Kaltoum Hassani [France] ; Mireille Mouroux [France] ; Georg Andrees Bohme [France] ; Jean-Marie Stutzmann [France] ; Jean Féger [France] | Riluzole reduces hyperactivity of subthalamic neurons induced by unilateral 6‐OHDA lesion in the rat brain |
| 000507 |
Paul Krack [France, Allemagne] ; Rajeev Kumar [États-Unis] ; Claire Ardouin [France] ; Patricia Limousin Dowsey [France, Royaume-Uni] ; John M. Mcvicker [États-Unis] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] | Mirthful laughter induced by subthalamic nucleus stimulation |
| 000508 |
Jean-Louis Montastruc [France] ; Karine Desboeuf [France] ; Maryse Lapeyre-Mestre [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Christine Brefel-Courbon [France] | Long‐term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease |
| 000510 |
Olivier Rascol [France] ; I. Arnulf [France] ; H. Peyro-Saint Paul [France] ; C. Brefel-Courbon [France] ; M. Vidailhet [France] ; C. Thalamas [France] ; A. M. Bonnet [France] ; S. Descombes [France] ; B. Bejjani [France] ; N. Fabre [France] ; J. L. Montastruc [France] ; Yves Agid [France] | Idazoxan, an alpha‐2 antagonist, and L‐DOPA‐induced dyskinesias in patients with Parkinson's disease |
| 000511 |
E. Apartis [France] ; F. Tison [France] ; P. Arné [France] ; C. P. Jedynak [France] ; M. Vidailhet [France] | Fast orthostatic tremor in Parkinson's disease mimicking primary orthostatic tremor |
| 000513 |
Hélène Turmel [France] ; Andreas Hartmann [France] ; Karine Parain [France] ; Aicha Douhou [France] ; Anu Srinivasan [États-Unis] ; Yves Agid [France] ; Etienne C. Hirsch [France] | Caspase‐3 activation in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐treated mice |
| 000524 |
Matt Farrer [États-Unis] ; Alain Destée [France] ; Estelle Becquet [France] ; Fabienne Wavrant-De Vrièze [États-Unis, France] ; Vincent Mouroux [France] ; Florence Richard [France] ; Luc Defebvre [France] ; Sarah Lincoln [États-Unis] ; John Hardy [États-Unis] ; Philippe Amouyel [France] ; Marie-Christine Chartier-Harlin [France] | Linkage exclusion in French families with probable Parkinson's disease |
| 000526 |
Boulos Paul Bejjani ; Isabelle Arnulf ; Marie Vidailhet ; Bernard Pidoux [France] ; Philippe Damier ; Savvas Papadopoulos ; Anne-Marie Bonnet ; Philippe Cornu ; Didier Dormont ; Yves Agid [France] | Irregular jerky tremor, myoclonus, and thalamus: A study using low‐frequency stimulation |
| 000534 |
Franck Durif [France] ; Marie Vidailhet [France] ; Bérangère Debilly [France] ; Yves Agid [France] | Worsening of levodopa‐induced dyskinesias by motor and mental tasks |
| 000535 |
Jean Louis Montastruc [France] ; Olivier Rascol [France] ; Jean-Michel Senard [France] | Treatment of Parkinson's disease should begin with a dopamine agonist |
| 000541 |
Gregor K. Wenning [Autriche] ; Georg Ebersbach [Autriche] ; Marc Verny [France] ; K. Ray Chaudhuri [Royaume-Uni] ; Kurt Jellinger [Autriche] ; Ann Mckee [États-Unis] ; Werner Poewe [États-Unis] ; Irene Litvan [États-Unis] | Progression of falls in postmortem‐confirmed Parkinsonian disorders |
| 000543 |
Luc J. P. Defebvre [France] ; Philippe Derambure [France] ; Jean-Louis Bourriez [France] ; François Cassim [France] ; Jean Daniel Guieu [France] ; Alain Destée [France] | Motor programming is more affected in progressive supranuclear palsy than in Parkinson's disease: A spatiotemporal study of event‐related desynchronization |
| 000548 |
Gilles-Louis Defer [France] ; Hakan Widner [Suède] ; Rose-Marie Marié [France] ; Philippe Rémy [France] ; Marc Levivier [Belgique] | Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT‐PD) |
| 000552 |
Jean-Louis Montastruc [France] ; Marc Ziegler [France] ; Olivier Rascol [France] ; Muriel Malbezin [France] | A randomized, double‐blind study of a skin patch of a dopaminergic agonist, piribedil, in Parkinson's disease |
| 000559 |
P. Krack [France] ; Abdelhamid Benazzouz [France] ; Pierre Pollak [France] ; Patricia Limousin [France] ; Brigitte Piallat [France] ; Dominique Hoffmann [France] ; Jing Xie [France] ; Alim-Louis Benabid [France] | Treatment of tremor in Parkinson's disease by subthalamic nucleus stimulation |
| 000562 |
Hagai Bergman ; Aeyal Raz ; Ariela Feingold ; Asaph Nini ; Israel Nelken ; Ben-Pazi Hilla ; David Hansel [France] ; Avinoam Reches | Physiology of MPTP Tremor |
| 000564 |
Nelly Fabre [France] ; Christine Brefel [France] ; Umberto Sabatini [Italie] ; Pierre Celsis [France] ; Jean Louis Montastruc [France] ; François Chollet [France] ; Rascol [France] | Normal frontal perfusion in patients with frozen gait |
| 000565 |
Alim-Louis Benabid [France] ; A. Benazzouz [France] ; D. Hoffmann [France] ; P. Limousin [France] ; P. Krack [France] ; Pierre Pollak [France] | Long‐Term Electrical Inhibition of Deep Brain Targets in Movement Disorders |
| 000567 |
Paul Krack [France] ; Pierre Pollak [France] ; Patricia Limousin [France] ; Dominique Hoffmann [France] ; Abdelhamid Benazzouz [France] ; Alim-Louis Benabid [France] | Inhibition of levodopa effects by internal pallidal stimulation |
| 000570 |
I. Delalande [France] ; Jc. Hache [France] ; G. Forzy [France] ; M. Bughin [France] ; J. Benhadjali [France] ; A. Destée [France] | Do visual‐evoked potentials and spatiotemporal contrast sensitivity help to distinguish idiopathic Parkinson's disease and multiple system atrophy? |
| 000572 |
Potagas [France] ; George Dellatolas [France] ; Marc Ziegler [France] ; Jean Leveteau [France] ; Nguyen Bathien [France] ; Patrick Mac Leod [France] ; Pierre Rondot [France] | Clinical assessment of olfactory dysfunction in Parkinson's disease |
| 000581 |
Bonnet [France] ; J. Pichon [France] ; M. Vidailhet [France] ; N. Gouider-Khouja [France] ; G. Robain [France] ; M. Perrigot [France] ; Yves Agid [France] | Urinary disturbances in striatonigral degeneration and parkinson's disease: Clinical and urodynamic aspects |
| 000583 |
Mohamed Jaber [États-Unis, France] ; Sara Jones [États-Unis] ; Bruno Giros [États-Unis] ; Caron [États-Unis] | The dopamine transporter: A crucial component regulating dopamine transmission |
| 000589 |
Tison [France] ; Pascale Barberger-Gateau [France] ; Bénédicte Dubroca [France] ; Patrick Henry [France] ; Jean-François Dartigues [France] | Dependency in parkinson's disease: A population‐based survey in nondemented elderly subjects |
| 000591 |
Nathalie Andreu [France] ; Christine Damase-Michel [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Montastruc [France] | A dose‐ranging study of selegiline in patients with Parkinson's disease: Effect on platelet monoamine oxidase activity |
| 000601 |
Tison [France] ; L. Wiart [France] ; M. Guatterie [France] ; N. Fouillet [France] ; V. Lozano [France] ; P. Henry [France] ; M. Barat [France] | Effects of central dopaminergic stimulation by apomorphine on swallowing disorders in Parkinson's disease |
| 000603 |
Limousin [France] ; Pierre Pollak [France] ; Dominique Hoffmann [France] ; Abdelhamid Benazzouz [France] ; Jean Edmond Perret [France] ; Alim-Louis Benabid [France] | Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients |
| 000608 |
Gouider‐Khouja [France] ; Marie Vidailhet [France] ; Anne-Marie Bonnet [France] ; Jacques Pichon [France] ; Yves Agid [France] | “Pure” striatonigral degeneration and Parkinson's disease: A comparative clinical study |
| 000617 |
Limousin [France] ; Pierre Pollak [France] ; Abdelhamid Benazzouz [France] ; Dominique Hoffmann [France] ; Emmanuel Broussolle [France] ; Jean Edmond Perret [France] ; Alim-Louis Benabid [France] | Bilateral subthalamic nucleus stimulation for severe Parkinson's disease |
| 000618 |
Rascol [France] ; U. Sabatini [Italie] ; N. Fabre [France] ; J. M. Senard [France] ; M. Simonetta-Moreau [France] ; J. L. Montastruc [France] ; M. Clanet [France] ; A. Rascol [France] | Abnormal vestibuloocular reflex cancellation in multiple system atrophy and progressive supranuclear palsy but not in Parkinson's disease |
| 000629 |
Rascol [France] ; Nelly Fabre [France] ; Olivier Blin [France] ; Janet Poulik [France] ; Umberto Sabatini [France] ; Jean-Michel Senard [France] ; Michèle Ané [France] ; Jean-Louis Montastruc [France] ; André Rascol [France] | Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease |
| 000630 |
Roberto Marconi [France, Italie] ; Dominique Lefebvre-Caparros [France] ; Anne-Marie Bonnet [France] ; Marie Vidailhet [France] ; Bruno Dubois [France] ; Agid [France] | Levodopa‐induced dyskinesias in Parkinson's disease phenomenology and pathophysiology |
| 000638 |
Broussolle [France] ; L. Cinotti [France] ; Pierre Pollak [France] ; P. Landais [France] ; D. Le Bars [France] ; G. Galy [France] ; F. Lavenne [France] ; Y. Khalfallah [France] ; G. Chazot [France] ; F. Mauguière [France] | Relief of akinesia by apomorphine and cerebral metabolic changes in parkinson's disease |
| 000675 |
Maloteaux [Belgique] ; E. C. Laterre [Belgique] ; P. M. Laduron [France] ; F. Javoy-Agid [France] ; Yves Agid [France] | Decrease of serotonin‐S2 receptors in temporal cortex of patients with Parkinson's disease and progressive supranuclear palsy |
| 000677 |
J. L. Montastruc [France] ; Celsis [France] ; A. Agniel [France] ; J. F. Demonet [France] ; B. Doyon [France] ; M. Puel [France] ; J. P. Marc-Vergnes [France] ; A. Rascol [France] | Levodopa‐induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson's disease |
| 000678 |
A. M. Bonnet [France] ; Tell ; P. J. Schechter ; J. Grove ; M. H. Saint-Hilaire [France] ; Y. De Smet [France] ; Yves Agid [France] | Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea |
